encroach
发表于 2025-3-21 17:43:49
书目名称Sandostatin® in the Treatment of Acromegaly影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0860809<br><br> <br><br>书目名称Sandostatin® in the Treatment of Acromegaly影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0860809<br><br> <br><br>书目名称Sandostatin® in the Treatment of Acromegaly网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0860809<br><br> <br><br>书目名称Sandostatin® in the Treatment of Acromegaly网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0860809<br><br> <br><br>书目名称Sandostatin® in the Treatment of Acromegaly被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0860809<br><br> <br><br>书目名称Sandostatin® in the Treatment of Acromegaly被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0860809<br><br> <br><br>书目名称Sandostatin® in the Treatment of Acromegaly年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0860809<br><br> <br><br>书目名称Sandostatin® in the Treatment of Acromegaly年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0860809<br><br> <br><br>书目名称Sandostatin® in the Treatment of Acromegaly读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0860809<br><br> <br><br>书目名称Sandostatin® in the Treatment of Acromegaly读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0860809<br><br> <br><br>
embolus
发表于 2025-3-21 22:25:05
Medical Treatment of Acromegaly. Dopaminergic Agonists and Long-Acting Somatostatin,The medical treatment of acromegaly is of value because neurosurgery and Rx therapy may be unsuccessful in this disease.
Eeg332
发表于 2025-3-22 02:47:50
,Experience with Sandostatin® in Various Groups of Acromegalic Patients,The availability, for clinical use, of the somatostatin analogue SMS 201–995 (Sandostatin.) has opened new doors in the treatment of acromegaly . We report here our experience with Sandostatin used either as a chronic medical therapy or as a preparation to surgery.
Madrigal
发表于 2025-3-22 07:39:28
,Treatment of Acromegaly with SMS 201–995 (Sandostatin®): Clinical, Biochemical and Morphologic StudCurrent therapy of acromegaly is unsatisfactory, and in a significant proportion of acromegalic patients the disease remains clinically active after all approved therapeutic modalities (surgery, irradiation and bromocriptine) have been exhausted.
Synchronism
发表于 2025-3-22 09:30:31
http://reply.papertrans.cn/87/8609/860809/860809_5.png
屈尊
发表于 2025-3-22 16:28:18
http://reply.papertrans.cn/87/8609/860809/860809_6.png
headlong
发表于 2025-3-22 18:01:21
https://doi.org/10.1007/978-3-642-73694-0cardiovascular; cardiovascular disease; clinical trial; dopamine; growth; growth hormone; hormone; hyperten
spinal-stenosis
发表于 2025-3-22 23:12:09
,Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995 (Sandostatin®),ts efficacy and long-term usefulness in 12 patients with therapy-resistant disease. All had been previously treated by transsphenoidal surgery, irradiation, bromocriptine or a combination of these but their GH concentrations had been insufficiently lowered. Duration of Sandostatin treatment was at least 12 months in all patients.
manifestation
发表于 2025-3-23 02:01:42
,Observations During a Clinical Trial of Sandostatin® in Acromegalic Patients,viously untreated or had been unsuccessfully treated with bromocriptine. At entrance to the study they had 24-h serum growth hormone means ranging from 19.4 to 154 ng/ml and pronounced clinical evidence of active acromegaly.
Evacuate
发表于 2025-3-23 08:35:30
http://reply.papertrans.cn/87/8609/860809/860809_10.png